Home healthcare provider Addus HomeCare (NASDAQ: ADUS) will be reporting results this Monday after market hours. Here’s what to look for.
Addus HomeCare beat analysts’ revenue expectations by 0.8% last quarter, reporting revenues of $349.4 million, up 21.8% year on year. It was a satisfactory quarter for the company, with a narrow beat of analysts’ revenue estimates.
Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Addus HomeCare’s revenue to grow 22.3% year on year to $354.5 million, improving from the 7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.53 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Addus HomeCare’s peers in the senior health, home health & hospice segment, some have already reported their Q3 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 14.7%, beating analysts’ expectations by 5.3%, and Option Care Health reported revenues up 12.2%, topping estimates by 1.4%. BrightSpring Health Services’s stock price was unchanged after the resultswhile Option Care Health was down 9.2%.
Read our full analysis of BrightSpring Health Services’s results here and Option Care Health’s results here.
Investors in the senior health, home health & hospice segment have had steady hands going into earnings, with share prices flat over the last month. Addus HomeCare is up 1.8% during the same time and is heading into earnings with an average analyst price target of $141.91 (compared to the current share price of $116.89).
P.S. STOP buying the AI stocks everyone’s talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
